3
3

RAPID Reserve Act

7/2/2025, 6:06 PM

Summary of Bill HR 3955

The bill H.R. 3955 of the 119th Congress, introduced on June 12, 2025, aims to enhance supply chain resiliency for critical drug products with vulnerable supply chains. It seeks to establish and maintain reserves of critical drugs and active pharmaceutical ingredients to mitigate supply disruptions during drug shortages or public health emergencies.

Current Status of Bill HR 3955

Bill HR 3955 is currently in the status of Bill Introduced since June 12, 2025. Bill HR 3955 was introduced during Congress 119 and was introduced to the House on June 12, 2025.  Bill HR 3955's most recent activity was Referred to the House Committee on Energy and Commerce. as of June 12, 2025

Bipartisan Support of Bill HR 3955

Total Number of Sponsors
3
Democrat Sponsors
3
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
1
Democrat Cosponsors
0
Republican Cosponsors
1
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 3955

Primary Policy Focus

Health

Alternate Title(s) of Bill HR 3955

To improve supply chain resiliency for critical drug products with vulnerable supply chains and ensure that reserves of critical drugs and active pharmaceutical ingredients are maintained to prevent supply disruptions in the event of drug shortages or public health emergencies.
To improve supply chain resiliency for critical drug products with vulnerable supply chains and ensure that reserves of critical drugs and active pharmaceutical ingredients are maintained to prevent supply disruptions in the event of drug shortages or public health emergencies.

Comments